Abstract
The irrational use of broad-spectrum antibiotics has led to increasing resistance of bacteria to antibiotics, and the emergence of the plasmid-mediated colistin resistance gene mcr-1 has led to the dilemma of infections with no available cure. Here, we have found a potential MCR-1 inhibitor for use against infections caused by MCR-1 positive resistant bacteria. A checkerboard MIC (minimum inhibitory concentration) assay, growth curve assay, kill curve assay, cytotoxicity assay, molecular dynamics simulation analysis, Western blot assay and mouse pneumonia model in vivo protection rate assay were used to evaluate the synergy effect between genistein and polymyxins. The results showed that genistein could restore the bactericidal activity against MCR-1-positive strains for which there was no antibacterial activity, and reduce the bacterial load to some extent. Genistein does not inhibit the expression of MCR-1, but inhibits the binding of MCR-1 to its substrate by binding to the amino acids of the active region of MCR-1, thereby inhibiting the biological activity of MCR-1. The in vivo results also showed that the protection rate of mice treated with the combination therapy of genistein and polymyxins increased by 20% compared to that of mice treated with polymyxins alone. Our results confirm that genistein is an inhibitor of MCR-1 and promote its potential use in combination with polymyxins to treat severe infections caused by MCR-1 positive Enterobacteriaceae.
Similar content being viewed by others
References
Xu YC, Lin JX, Cui T, Srinivas S, Feng YJ (2018) Mechanistic insights into transferable polymyxin resistance among gut bacteria. J Biol Chem 293:4350–4365
Lukac PJ, Bonomo RA, Logan LK (2015) Extended-spectrum alpha-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat. Clin Infect Dis 60:1389–1397
Meropol SB, Haupt AA, Debanne SM (2018) Incidence and outcomes of infections caused by multidrug-resistant Enterobacteriaceae in children, 2007–2015. J Pediatr Infect Dis Soc 7:36–45
Gao RS, Hu YF, Li ZC, Sun J, Wang QJ, Lin JX, Ye HY, Liu F, Srinivas S, Li DF et al (2016) Dissemination and mechanism for the MCR-1 colistin resistance. PLoS Pathog 12:1005957
Stansly PG, Shepherd RG, White HJ (1947) Polymyxin: a new chemotherapeutic agent. Bull Johns Hopkins Hosp 81:43–54
Falagas ME, Rafailidis PI (2008) Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives. Expert Opin Investig Drugs 17:973–981
Ruiz J, Nunez ML, Perez J, Simarro E, Martinez-Campos L, Gomez J (1999) Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period. Eur J Clin Microbiol Infect Dis 18:292–295
Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian GB, Dong BL, Huang XH et al (2016) Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161–168
Yang YQ, Li YX, Song T, Yang YX, Jiang W, Zhang AY, Guo XY, Liu BH, Wang YX, Lei CW et al (2017) Colistin resistance gene mcr-1 and its variant in Escherichia coli isolates from chickens in China. Antimicrob Agents Chemother 61:5
Du H, Chen L, Tang YW, Kreiswirth BN (2016) Emergence of the mcr-1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae. Lancet Infect Dis 16:287–288
Yao X, Doi YH, Zeng L, Lv LC, Liu JH (2016) Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1. Lancet Infect Dis 16:288–289
Malhotra-Kumar S, Xavier BB, Das AJ, Lammens C, Hoang HTT, Pham NT, Goossens H (2016) Colistin-resistant Escherichia coli harbouring mcr-1 isolated from food animals in Hanoi, Vietnam. Lancet Infect Dis 16:286–287
Hirata F, Harada T, Corcoran GB, Hirata A (2014) Dietary flavonoids bind to mono-ubiquitinated annexin A1 in nuclei, and inhibit chemical induced mutagenesis. Mutat Res 759:29–36
Ekambaram P, Balan C, Susai CJ (2016) Genistein attenuates oxidative damage in preeclamptic placental trophoblast. Hypertens Pregnancy 35:250–263
Kang NH, Shin HC, Oh S, Lee KH, Lee YB, Choi KC (2016) Soy milk digestion extract inhibits progression of prostate cancer cell growth via regulation of prostate cancer-specific antigen and cell cycle-regulatory genes in human LNCaP cancer cells. Mol Med Rep 14:1809–1816
Zhang M, Wang K, Chen L, Yin B, Song Y (2016) Is phytoestrogen intake associated with decreased risk of prostate cancer? A systematic review of epidemiological studies based on 17,546 cases. Andrology 4:745–756
Si HW, Liu DM (2008) Genistein, a soy phytoestrogen, upregulates the expression of human endothelial nitric oxide synthase and lowers blood pressure in spontaneously hypertensive rats. J Nutr 138:297–304
Zhou YL, Wang JF, Guo Y, Liu XQ, Liu SL, Niu XD, Wang Y, Deng XM (2019) Discovery of a potential MCR-1 inhibitor that reverses polymyxin activity against clinical mcr-1-positive Enterobacteriaceae. J Infect 78:364–372
Partridge SR, Kwong SM, Firth N, Jensen SO (2018) Mobile genetic elements associated with antimicrobial resistance. Clin Microbiol Rev 31:4
Ganai AA, Farooqi H (2015) Bioactivity of genistein: a review of in vitro and in vivo studies. Biomed Pharmacother 76:30–38
Lu YL, Li WF, Yang XB (2018) Soybean soluble polysaccharide enhances absorption of soybean genistein in mice. Food Res Int 103:273–279
McClain RM, Wolz E, Davidovich A, Pfannkuch F, Edwards JA, Bausch J (2006) Acute, subchronic and chronic safety studies with genistein in rats. Food Chem Toxicol 44:56–80
Funding
This work was supported by the National Key Technology R&D Program (Grant No. 2016YFD05013).
Author information
Authors and Affiliations
Contributions
Study design: LP, YW; Experimental studies: YW, XL; Data analysis/interpretation: XS, ZW; Statistical analysis: YW, DW; Manuscript preparation: LP, YW.
Corresponding authors
Ethics declarations
Conflict of interest
All authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, Y., Liu, X., Sun, X. et al. A Potential Inhibitor of MCR-1: An Attempt to Enhance the Efficacy of Polymyxin Against Multidrug-Resistant Bacteria. Curr Microbiol 77, 3256–3263 (2020). https://doi.org/10.1007/s00284-020-02096-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00284-020-02096-y